SEC Comment Letter 0000000000-25-003282 to Tiziana Life Sciences Ltd (TLSA)
Tiziana Life Sciences Ltd
Date: March 27, 2025 · CIK: 0001723069 · Accession: 0000000000-25-003282
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286064
Letter
Re: Tiziana Life Sciences Ltd Registration Statement on Form F-3 Filed March 24, 2025 File No. 333-286064 Dear Ivor Elrifi:
March 26, 2025
Ivor Elrifi Chief Executive Officer Tiziana Life Sciences Ltd 420 Lexington Avenue, Suite 2525 New York, NY 10170
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Jeffrey J. Fessler, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 26, 2025 Ivor Elrifi Chief Executive Officer Tiziana Life Sciences Ltd 420 Lexington Avenue, Suite 2525 New York, NY 10170 Re: Tiziana Life Sciences Ltd Registration Statement on Form F-3 Filed March 24, 2025 File No. 333-286064 Dear Ivor Elrifi: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeffrey J. Fessler, Esq. </TEXT> </DOCUMENT>